ticker

More Success Ahead for Gilead

kalina
30 Sep, 2002
New York City

Having just achieved its first profitable quarter, and supported by rising sales and launch of a new drug, biotech company Gilead Sciences is poised to attain more success ahead.

Risk Flavor of Organic Food Stocks

iliana
27 Sep, 2002
New York City

Organic food chains Whole Foods and Wild Oats offer consumers products that ensure a healthier way of life. Currently overpriced, their stocks are likely to be long-term favorites

Wireless Start-ups Still Wired to VC Cash

vanya
18 Sep, 2002
New York City

Although gloom hangs over the wireless industry, VCs are still finding some diamonds in the rough

Busy Fall for Biotechs

kalina
17 Sep, 2002
New York City

Important symposiums and regulatory reviews of drugs this September are likely to spark investor interest in biotech stocks and prompt a rally in case of positive developments.

Looking for Flexible Investment Options

vicky
16 Sep, 2002
New York City

In the current depressed market scenario, investors can easily avoid risk by putting money in the bank - but diversified financial stocks appear to be a good, flexible alternative

Wet Seal Beckons Investors

iliana
12 Sep, 2002
New York City

Supported by future growth potential and its current trimmed, attractive valuations, the stock of teen apparel retailer, Wet Seal, seems to be in fine shape to woo investors

Gains in the Offing from Biotech Stocks

kalina
06 Sep, 2002
New York City

Low valuations of industry top dogs and demographic changes in U.S. society offer good opportunities to investors seeking long-term gains. Find out which companies have real value.

Seeking Refuge in REITs

vanya
04 Sep, 2002
New York City

A shaky market scenario has forced investors to diversify their portfolios and seek refuge in real estate, particularly REITs, - due to their relative stability and high yields.

Bumpy Ride Ahead for Harley-Davidson

iliana
30 Aug, 2002
New York City

For 16 straight years Harley-Davidson has given both investors and customers the same service - a smooth ride. But with stiff competition and aging riders the ride may turn bumpy.

Chasing the Banker

vicky
23 Aug, 2002
New York City

Given the market uncertainty it

NPS Pharmaceuticals: Success Within Sight

kalina
22 Aug, 2002
New York City

NPS Pharmaceuticals has been showing strength amidst the market uncertainty and is likely to perform even better as long as investor sentiment remains positive.

MEMS: Macro Bets on Micro Devices

vanya
21 Aug, 2002
New York City

Sometimes, something small draws big bets. MEMS is one such example - it has lured scores of VCs and players, big and small. Will the fledgling technology deliver on its promise?

Williams-Sonoma: Furnishing Value for Money

iliana
14 Aug, 2002
New York City

Riding high in the robust housing market, Williams-Sonoma has consistently reported strong results. And though its price has soared, the stock is still a worthy long-term holding.

Mergers Emerging in the Biotech Sector

kalina
13 Aug, 2002
New York City

The increasing pressure on biotech companies to get new drugs to the market has triggered a new wave of merger and acquisition activity in the sector.

Life Sciences Enter the VC Mainstream

vanya
09 Aug, 2002
New York City

In contrast to the gloom surrounding public biotech players, VCs have pushed life sciences into the mainstream, pouring funds into biotech, medical devices and healthcare start-ups

Market Update